# Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)

> **NCT00978055** · PHASE1 · COMPLETED · sponsor: **Mylan Pharmaceuticals Inc** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 1: Liothyronine Sodium Tablets
- **DRUG:** 2: Cytomel® Tablets

## Key facts

- **NCT ID:** NCT00978055
- **Lead sponsor:** Mylan Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2009-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978055, "Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00978055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*